Measurement of HAMA and Anti-Idiotypic Antibodies

  • Steve Nicholson
Part of the Methods in Molecular Medicine book series (MIMM, volume 40)


Murine monoclonal antibodies (mAbs) when administered to patients are perceived much as any other foreign antigen: an immune response is usually mounted against them, the result of which is the generation of human antimouse antibodies (HAMA). Even in the absence of such immunization some patients may possess HAMA activity because of polyclonal IgM rheumatoid factors that crossreact with Fc epitopes on both human and mouse IgG (1).


Wash Buffer Chromogenic Substrate Sodium Periodate Charing Cross Hospital Carboxymethyl Dextran 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Courtenay-Luck, N., Epenetos, A. A., Winearls, C. G., and Ritter, M. A. (1987) Preexisting human anti-murine immunoglobulin reactivity due to polyclonal rheu-matoid factors. Cancer Res. 47, 4520–4525.PubMedGoogle Scholar
  2. 2.
    Boscato, L. and Stuart, M. (1988) Heterophilic antibodies: a problem for all immunoassays. Clin. Chem. 34, 27–33.PubMedGoogle Scholar
  3. 3.
    Boerman, O., Segers, M. F., Poels, L. G., et al. (1990) Heterophilic antibodies in human sera causing falsely increased results in the CA125 immunofluorometric assay. Clin. Chem. 36, 888–891.PubMedGoogle Scholar
  4. 4.
    Kaminski, M. S., Zasadny, K. R., Francis, J. R., et al. (1996) Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J. Clin. Oncol. 14, 1974–1981.PubMedGoogle Scholar
  5. 5.
    Herlyn, D., Wettendorff, M., Schmoll, E., et al. (1987) Anti-idiotype immunization of cancer patients: modulation of the immune response. Proc. Nat. Acad. Sci. USA 84, 8055–8059.CrossRefPubMedGoogle Scholar
  6. 6.
    Nicholson, S., Fox, M., Epenetos, A., and Rustin, G. (1996) Immunoglobulin inhibiting reagent: evaluation of a new method for eliminating spurious elevations in CA125 caused by HAMA. Int. J. Biol. Markers 11, 46–49.PubMedGoogle Scholar
  7. 7.
    Cheung, N.-K., et al. (1994) Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival. Cancer Res. 54, 2228–2233.PubMedGoogle Scholar
  8. 8.
    Tibben, J., Thomas, C. M., Massuger, L. F., et al. (1995) Humoral anti-OV-TL-3 response after the intravenous administration of radiolabelled Fab’ or F(ab’)2 fragments in ovarian cancer patients. Nucl. Med. Commun. 16, 853–859.CrossRefPubMedGoogle Scholar
  9. 9.
    McIntyre, J. and Higgins, N. (1995) A novel and rapid assay to detect anti-idiotypic anti-OKT3 antibodies. Transplantation 59, 1507–1508.PubMedGoogle Scholar
  10. 10.
    Nicholson, S., Gallop, J. L., Law, P., et al. (1999) Monitoring antibody responses to cancer vaccination with a resonant mirror biosensor. Lancet 353, 808.CrossRefPubMedGoogle Scholar
  11. 11.
    George, A., Danga, R., and Gooden, C. (1995) Quantitative and qualitative detection of serum antibodies using a resonant mirror biosensor. Tumor Target. 1, 245–250.Google Scholar
  12. 12.
    George, A., Gallop, J., and Rashid, M. (1997) Kinetics of biomolecular interactions. Expert Opin. Ther. Patents 7, 947–963.CrossRefGoogle Scholar
  13. 13.
    Madiyalakan, R., Sykes, T. R., Dharampaul, S., et al. (1995) Anti-idiotype induction therapy: evidence for the induction of immune response through the idiotype network in patients with ovarian cancer after administration of anti-CA125 murine monoclonal antibody B43.13. Hybridoma 14, 199–203.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2000

Authors and Affiliations

  • Steve Nicholson

There are no affiliations available

Personalised recommendations